← Back to Search

Proof of Concept for Head and Neck Squamous Cell Carcinoma

Phase 2
Recruiting
Led By Rusha Patel, MD
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with suspected or diagnosed HNSCC undergoing planned 18F FDG PET/CT at the time of primary diagnosis or after completion of treatment.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
All Individual Drugs Already Approved

Summary

This is a proof-of-concept trial to compare 18F-FDG-PET/CT with NETSPOT (68Ga-DOTA-TATE), a commercially available radiotracer packet that utilizes 68Ga to image SSTR-specific tissue.

Eligible Conditions
  • Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Detection and Staging of Head and Neck Squamous Cell Carcinoma
Secondary study objectives
Detection of disease recurrence and metastasis following treatment
Detection of primary site for Head and Neck Squamous Cell Carcinoma

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Proof of ConceptExperimental Treatment1 Intervention
The isotope 68Ga, available as NETSPOT and 18F-FDG-PET/CT per established protocol will both be administered

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
185 Previous Clinical Trials
64,743 Total Patients Enrolled
Rusha Patel, MDPrincipal InvestigatorWest Virginia University
1 Previous Clinical Trials
62 Total Patients Enrolled
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top